Treatment Tips as COVID-19 Complicates CVD Management in Diabetes
COVID-19 and related cardio-renal-pulmonary damage can profoundly affect the cardiovascular risk management of people with diabetes. It is recommended to continue ACE inhibitors and angiotensin receptor blockers, both SGLT2 inhibitors and GLP-1 receptor agonists have anti-inflammatory activities, which might be beneficial for patients with COVID-19. However, several expert groups in diabetes have previously advised that […]
Cardiovascular disease and COVID-19
Respiratory illness is the dominant clinical manifestation of COVID-19; CVD involvement occurs rarely. Acute cardiac injury, defined as a significant elevation of cardiac troponins, is the most commonly reported cardiac abnormality in COVID-19 affecting ~8–12% of patients. A Chinese study reported the incidence of heart failure in 52% of COVID-19 patients who subsequently died and […]
Multiple Sclerosis to Have Milder COVID-19 Symptoms?
A cross-sectional study conducted on 543 Multiple Sclerosis patients suggested that most Multiple Sclerosis patients developed a mild course of COVID-19 infection. The study was conducted to identify suspected COVID-19 cases and associated factors in Multiple Sclerosis patients by interrogation over phone and evaluating the medical records. Common symptoms suspicious for COVID-19 infection included dyspnea, […]
Management of epilepsy, PTSD and depression: A Case
A 48-year-old man was diagnosed with refractory epilepsy and psychogenic nonepileptic seizures. Both diagnoses were confirmed by video-EEG monitoring. His MRI brain showed evidence of right hippocampal sclerosis. He was diagnosed to have depression and posttraumatic stress disorder (PTSD).
Treatment resistant epilepsy: A Case
A 48-year-old man was diagnosed with refractory epilepsy and psychogenic nonepileptic seizures. Both diagnoses were confirmed by video-EEG monitoring. His MRI brain showed evidence of right hippocampal sclerosis. He was diagnosed to have depression and posttraumatic stress disorder (PTSD).
Young Children with Obsessive Compulsive Disorder
Juvenile obsessive-compulsive disorder (OCD) often starts at the mean age of 10.3 years. However, OCD manifests at even younger age in some patients. An earlier age of onset and a longer duration of illness have been associated with increased persistence of OCD. Objective To understand the clinical presentation, diagnosis and possible treatment of OCD in […]